Literature DB >> 3998936

Vancomycin/aminoglycoside nephrotoxicity.

R P Dean, D J Wagner, M D Tolpin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998936     DOI: 10.1016/s0022-3476(85)80383-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  Antibacterial-induced nephrotoxicity in the newborn.

Authors:  V Fanos; L Cataldi
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 2.  Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.

Authors:  K A Rodvold; J A Everett; R D Pryka; D M Kraus
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

3.  Vancomycin intoxication in a preterm neonate.

Authors:  W J Tissing; M A Umans-Eckenhausen; J N van den Anker
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

Review 4.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 5.  Vancomycin ototoxicity and nephrotoxicity. A review.

Authors:  G R Bailie; D Neal
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 6.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 7.  Vancomycin: pharmacokinetics and administration regimens in neonates.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Vancomycin pharmacokinetics and dose recommendations for preterm infants.

Authors:  A James; G Koren; J Milliken; S Soldin; C Prober
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.